Taken together, our study clearly investigates the expression levels, clinical significances, and functions of Runx2, and identifies its upstream regulator Zic2 and downstream target NOLC1 in ccRCC. The gene discussed is NOLC1; the disease is nonpapillary renal cell carcinoma.